Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-
TL;DR: Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- (CAS 104160-22-7) is a chemical compound with molecular formula C27H28N2O5 and molecular weight 460.20 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
[(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl] 2-aminobenzoate
Also Known As: Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-, 17-(Cyclopropylmethyl)-14-hydroxy-6-oxo-5alpha-4,5-epoxymorphinan-3-yl 2-aminobenzoate
| Molecular Formula | C27H28N2O5 |
|---|---|
| Molecular Weight | 460.20 g/mol |
| LogP | 2.6212 |
| Topological Polar Surface Area | 102.09 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Exact Mass | 460.19983 |
| Heavy Atoms | 34 |
| Complexity | 1239.5214 |
Chemical Identifiers
| CAS Number | 104160-22-7 |
|---|---|
| SMILES | C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)OC(=O)C7=CC=CC=C7N)O5)O |
Product Overview
Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- (CAS 104160-22-7), with molecular formula C27H28N2O5 and molecular weight 460.20 g/mol. IUPAC: [(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl] 2-aminobenzoate.
Chemical Property Profile of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-
Property Insights of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-
The XLogP value of 2.6212 suggests moderate lipophilicity, balancing water solubility and membrane permeability for Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-. The TPSA of 102.09 Ų falls within the moderate polarity range, balancing permeability and solubility for Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-. Following Lipinski's Rule of Five, Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- has 2 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-?
The CAS number of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- is 104160-22-7.
What is the molecular formula of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-?
The molecular formula of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- is C27H28N2O5.
What is the molecular weight of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-?
The molecular weight of Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- is 460.20 g/mol.
Where can I buy Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-?
You can request a quote for Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)-?
Yes, KEHONG BIO provides custom synthesis services for Morphinan-6-one, 3-((2-aminobenzoyl)oxy]-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-, (5alpha)- and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.